Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

Microbio Co., Ltd. (4128) Announces Promising Results of

CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical...
16 hours ago
from: mypanhandle.com

Continue reading...
Cancer immunotherapy, Clinical trial, Microbio Co., Ltd., Pembrolizumab, Stage IIIB Non-Small Cell Lung Cancer
More about this